Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Broadcom
AVGO
|
$2.09B |
| 2 |
Mastercard
MA
|
$2.06B |
| 3 |
UnitedHealth
UNH
|
$1.3B |
| 4 |
Coca-Cola
KO
|
$1.17B |
| 5 |
Marsh & McLennan
MMC
|
$1.1B |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$1.55B |
| 2 |
Apple
AAPL
|
$1.51B |
| 3 |
JPMorgan Chase
JPM
|
$1.34B |
| 4 |
General Dynamics
GD
|
$1.25B |
| 5 |
Wells Fargo
WFC
|
$1.17B |
Sector Composition
| 1 | Technology | 21.49% |
| 2 | Healthcare | 18.42% |
| 3 | Financials | 15.97% |
| 4 | Consumer Discretionary | 9.49% |
| 5 | Industrials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Doximity
DOCS
$13B
| $675K | ﹤0.01% |
11,639
+4,983
| +75% | +$289K |
|
1677
Macy's
M
$4.64B
| $674K | ﹤0.01% |
53,688
-2,949
| -5% | -$37K |
|
1678
Jack Henry & Associates
JKHY
$11.8B
| $673K | ﹤0.01% |
3,685
+799
| +28% | +$146K |
|
1679
Roku
ROKU
$14B
| $673K | ﹤0.01% |
9,552
+675
| +8% | +$47.5K |
|
1680
Arrowhead Research
ARWR
$4.02B
| $670K | ﹤0.01% |
52,614
-2,782
| -5% | -$35.4K |
|
1681
Avita Medical
RCEL
$115M
| $669K | ﹤0.01% |
+82,206
| New | +$669K |
|
1682
Beam Therapeutics
BEAM
$2.11B
| $657K | ﹤0.01% |
33,631
-1,938
| -5% | -$37.8K |
|
1683
Ambev
ABEV
$34.8B
| $655K | ﹤0.01% |
281,129
-23,393
| -8% | -$54.5K |
|
1684
Franklin Covey
FC
$244M
| $655K | ﹤0.01% |
+23,700
| New | +$655K |
|
1685
Southern California Bancorp
BCAL
$556M
| $642K | ﹤0.01% |
44,788
-1,175
| -3% | -$16.8K |
|
1686
Eledon Pharmaceuticals
ELDN
$162M
| $639K | ﹤0.01% |
+188,485
| New | +$639K |
|
1687
Weatherford International
WFRD
$4.49B
| $617K | ﹤0.01% |
11,518
-19
| -0.2% | -$1.02K |
|
1688
Mine Safety
MSA
$6.67B
| $603K | ﹤0.01% |
4,113
-238
| -5% | -$34.9K |
|
1689
IDEAYA Biosciences
IDYA
$2.38B
| $598K | ﹤0.01% |
36,486
-3,304
| -8% | -$54.1K |
|
1690
Aquestive Therapeutics
AQST
$656M
| $596K | ﹤0.01% |
205,544
+25,932
| +14% | +$75.2K |
|
1691
Travere Therapeutics
TVTX
$1.93B
| $594K | ﹤0.01% |
33,170
-323
| -1% | -$5.79K |
|
1692
Array Technologies
ARRY
$1.37B
| $591K | ﹤0.01% |
+121,305
| New | +$591K |
|
|
VNET
1693
VNET Group
VNET
$2.13B
| $591K | ﹤0.01% |
+72,043
| New | +$591K |
|
1694
Akamai
AKAM
$11.3B
| $587K | ﹤0.01% |
7,298
+1,311
| +22% | +$106K |
|
1695
Amneal Pharmaceuticals
AMRX
$3.02B
| $587K | ﹤0.01% |
70,052
-3,967
| -5% | -$33.2K |
|
|
ARTV
1696
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$88.2M
| $582K | ﹤0.01% |
194,108
| – | – |
|
1697
Prudential Financial
PRU
$37.2B
| $578K | ﹤0.01% |
+5,175
| New | +$578K |
|
1698
Bio-Rad Laboratories Class A
BIO
$8B
| $575K | ﹤0.01% |
2,359
+1,549
| +191% | +$377K |
|
1699
Recursion Pharmaceuticals
RXRX
$2.01B
| $569K | ﹤0.01% |
107,476
-7,469
| -6% | -$39.5K |
|
1700
J.M. Smucker
SJM
$12B
| $556K | ﹤0.01% |
+4,695
| New | +$556K |
|